PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.22%
Growth of 2.22% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
2.69%
Cost growth of 2.69% versus flat Healthcare costs. Walter Schloss would verify cost control.
0.43%
Growth of 0.43% versus flat Healthcare gross profit. Walter Schloss would verify quality.
-1.75%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.01%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-0.35%
Operating expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
2.14%
Total costs change of 2.14% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
4.61%
D&A growth exceeding 1.5x Healthcare median of 0.23%. Jim Chanos would check for overinvestment.
4.16%
EBITDA growth exceeding 1.5x Healthcare median of 0.66%. Joel Greenblatt would investigate advantages.
1.89%
Margin change of 1.89% versus flat Healthcare. Walter Schloss would verify quality.
4.58%
Operating income growth exceeding 1.5x Healthcare median of 1.84%. Joel Greenblatt would investigate advantages.
2.31%
Margin change of 2.31% versus flat Healthcare. Walter Schloss would verify quality.
-1.72%
Other expenses reduction while Healthcare median is 9.38%. Seth Klarman would investigate advantages.
3.97%
Pre-tax income growth exceeding 1.5x Healthcare median of 1.72%. Joel Greenblatt would investigate advantages.
1.71%
Margin change of 1.71% versus flat Healthcare. Walter Schloss would verify quality.
4.95%
Tax expense change of 4.95% versus flat Healthcare. Walter Schloss would verify strategy.
3.45%
Net income growth 1.25-1.5x Healthcare median of 2.60%. Mohnish Pabrai would examine sustainability.
1.20%
Margin change of 1.20% versus flat Healthcare. Walter Schloss would verify quality.
3.44%
EPS growth 75-90% of Healthcare median of 4.26%. John Neff would investigate potential.
3.44%
Diluted EPS growth 75-90% of Healthcare median of 4.26%. John Neff would investigate potential.
-0.00%
Share count reduction while Healthcare median is 0.12%. Seth Klarman would investigate strategy.
-0.00%
Diluted share reduction while Healthcare median is 0.09%. Seth Klarman would investigate strategy.